Avanos Medical, Inc.
AVNS
$12.71
-$0.39-2.98%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.74% | 5.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.74% | 5.40% | |||
| Cost of Revenue | -4.78% | 5.29% | |||
| Gross Profit | -8.37% | 5.49% | |||
| SG&A Expenses | -21.15% | 37.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -223.08% | 316.67% | |||
| Total Operating Expenses | -7.96% | 10.98% | |||
| Operating Income | 17.05% | -46.67% | |||
| Income Before Tax | 102.31% | -4,526.32% | |||
| Income Tax Expenses | 113.19% | -752.78% | |||
| Earnings from Continuing Operations | 101.66% | -6,828.81% | |||
| Earnings from Discontinued Operations | -- | 81.25% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 101.66% | -9,339.53% | |||
| EBIT | 17.05% | -46.67% | |||
| EBITDA | 0.00% | -29.43% | |||
| EPS Basic | 101.66% | -9,337.43% | |||
| Normalized Basic EPS | 42.32% | -51.42% | |||
| EPS Diluted | 101.62% | -10,180.51% | |||
| Normalized Diluted EPS | 40.15% | -50.80% | |||
| Average Basic Shares Outstanding | 0.22% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.74% | -1.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||